During the low-pressure casting of extra-large size C95800 copper alloy components,traditional linear pressurization technique leads to a rapid surge of liquid metal inlet velocity at the regions where the mold cavity...During the low-pressure casting of extra-large size C95800 copper alloy components,traditional linear pressurization technique leads to a rapid surge of liquid metal inlet velocity at the regions where the mold cavity cross-section enlarges.This rapid increasement of liquid metal inlet velocity causes serious entrapment of gas and oxide films,and results in various casting defects such as the bifilm defects.These defects detrimentally deteriorate mechanical properties of the castings.To address this issue,an innovative nonlinear pressurization strategy timely matching to the casting structure was proposed.The pressurization rate decreases at sections where the cross-section widens,but it gradually increases as the liquid metal level rises.By this way,the inlet velocity remains below a critical threshold to prevent the entrapment of gas and oxide films.Comparative analyses involving numerical simulations and casting verification illustrate that the nonlinear pressurization technique,compared to the linear pressurization,effectively diminishes both the size and number of bifilm defects.Furthermore,the nonlinear pressurization method enhances the casting yield strength by 10%,tensile strength by 14%,and elongation by 10%.Examination through scanning electron microscopy highlights that the bifilm defects arising from the linear pressurization process result in the reduction of the castings’mechanical properties.These observations underscore the efficacy of nonlinear pressurization in enhancing the quality and reliability of gigantic castings,as exemplified by a 5.4-ton extra-large sized C95800 copper alloy propeller hub with complex structures in the current study.展开更多
Background:The association between free triiodothyronine(FT3)and long-term prognosis in dilated cardiomyopathy(DCM)patients has not been evaluated.The purpose of this study was to determine whether the level of FT3 co...Background:The association between free triiodothyronine(FT3)and long-term prognosis in dilated cardiomyopathy(DCM)patients has not been evaluated.The purpose of this study was to determine whether the level of FT3 could provide prognostic value in patients with DCM.Methods:Data of consecutive patients diagnosed with DCM were collected from October 2009 to December 2014.FT3 was measured by fluoroimmunoassay.Other biochemical markers,such as free thyroxin(FT4),thyroid-stimulating hormone,red blood cell,hemoglobin,blood urea nitrogen,and serum creatinine,were tested at the same time.Follow-up was performed every 3 months.The primary endpoint was all-cause mortality.Pearson analysis was used to evaluate the correlation of FT3 and other lab metrics with DCM patients’prognosis.The association of long-term mortality in DCM and FT3 was compared using Cox hazards model.Results:Data of 176 patients diagnosed with DCM were collected.Of them,24 patients missed FT3 values and six patients were lost to follow-up.Altogether,data of 146 patients were analyzed.During the median follow-up time of 79.9(53.5-159.6)months,nine patients lost,61 patients died(non-survival group),and 85 patients survived(survival group).FT3 was significantly lower in non-survival group than that in survival group(3.65±0.83 pmol/L vs.4.36±1.91 pmol/L;P=0.003).FT3 also showed a significantly positive correlation with red blood cell and hemoglobin,negatively correlated with age,blood urea nitrogen and serum creatinine(P<0.05),respectively.Patients in the group of lower FT3 levels(FT3≤3.49 pmol/L)suffered from a higher risk of all-cause mortality(P for log-rank=0.001).In multivariate Cox regression analysis,FT3 level was significantly associated with all-cause mortality(hazard ratio:0.70,95%confidence interval 0.52-0.95,P for trend=0.021).Conclusion:Low levels of FT3 were associated with increased all-cause mortality in patients with DCM.展开更多
基金supported by the National Natural Science Foundation of China(Granted Nos.51827801,52371152)the Foundation of National Key Laboratory of Precision Hot Processing of Metals(Granted No.DCQQ2790100724).
文摘During the low-pressure casting of extra-large size C95800 copper alloy components,traditional linear pressurization technique leads to a rapid surge of liquid metal inlet velocity at the regions where the mold cavity cross-section enlarges.This rapid increasement of liquid metal inlet velocity causes serious entrapment of gas and oxide films,and results in various casting defects such as the bifilm defects.These defects detrimentally deteriorate mechanical properties of the castings.To address this issue,an innovative nonlinear pressurization strategy timely matching to the casting structure was proposed.The pressurization rate decreases at sections where the cross-section widens,but it gradually increases as the liquid metal level rises.By this way,the inlet velocity remains below a critical threshold to prevent the entrapment of gas and oxide films.Comparative analyses involving numerical simulations and casting verification illustrate that the nonlinear pressurization technique,compared to the linear pressurization,effectively diminishes both the size and number of bifilm defects.Furthermore,the nonlinear pressurization method enhances the casting yield strength by 10%,tensile strength by 14%,and elongation by 10%.Examination through scanning electron microscopy highlights that the bifilm defects arising from the linear pressurization process result in the reduction of the castings’mechanical properties.These observations underscore the efficacy of nonlinear pressurization in enhancing the quality and reliability of gigantic castings,as exemplified by a 5.4-ton extra-large sized C95800 copper alloy propeller hub with complex structures in the current study.
基金funded by grants from the National Key Research and Development Program of China(No.2016YFE0117000)the National Natural Science Foundation of China(Nos.81901410,81871113)+2 种基金Qinghai Provincial Natural Science Fund(No.2017-ZJ-769)333 project of Jiangsu Province(No.BRA2017544)Changzhou Science and Technology Bureau(No.CJ20190102)。
文摘Background:The association between free triiodothyronine(FT3)and long-term prognosis in dilated cardiomyopathy(DCM)patients has not been evaluated.The purpose of this study was to determine whether the level of FT3 could provide prognostic value in patients with DCM.Methods:Data of consecutive patients diagnosed with DCM were collected from October 2009 to December 2014.FT3 was measured by fluoroimmunoassay.Other biochemical markers,such as free thyroxin(FT4),thyroid-stimulating hormone,red blood cell,hemoglobin,blood urea nitrogen,and serum creatinine,were tested at the same time.Follow-up was performed every 3 months.The primary endpoint was all-cause mortality.Pearson analysis was used to evaluate the correlation of FT3 and other lab metrics with DCM patients’prognosis.The association of long-term mortality in DCM and FT3 was compared using Cox hazards model.Results:Data of 176 patients diagnosed with DCM were collected.Of them,24 patients missed FT3 values and six patients were lost to follow-up.Altogether,data of 146 patients were analyzed.During the median follow-up time of 79.9(53.5-159.6)months,nine patients lost,61 patients died(non-survival group),and 85 patients survived(survival group).FT3 was significantly lower in non-survival group than that in survival group(3.65±0.83 pmol/L vs.4.36±1.91 pmol/L;P=0.003).FT3 also showed a significantly positive correlation with red blood cell and hemoglobin,negatively correlated with age,blood urea nitrogen and serum creatinine(P<0.05),respectively.Patients in the group of lower FT3 levels(FT3≤3.49 pmol/L)suffered from a higher risk of all-cause mortality(P for log-rank=0.001).In multivariate Cox regression analysis,FT3 level was significantly associated with all-cause mortality(hazard ratio:0.70,95%confidence interval 0.52-0.95,P for trend=0.021).Conclusion:Low levels of FT3 were associated with increased all-cause mortality in patients with DCM.
